Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
LONDON and NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Renalytix plc (Nasdaq:RNLX) (LSE:RENX) announces that it has formally submitted a hearing request to the Nasdaq Hearings Panel (the “Panel”), which request has now stayed the suspension of the Company’s securities pending the Panel’s decision as described below. Throughout the hearings process, pending the Panel’s decision, the Company’s American Depositary Shares (“ADSs”) will continue trading on The Nasdaq Global Market under the symbol “RNLX.”